Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and Atherosclerotic Parkinsonism

3,4-dihydroxyphenylethanol has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kumar, R; Pathania, A; Sandhir, R1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylethanol and Atherosclerotic Parkinsonism

ArticleYear
Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson's disease model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 139

    Topics: Animals; Antiparkinson Agents; Blood Platelets; Computer Simulation; Dopamine; Dopaminergic Neurons; Humans; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Dynamics Simulation; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Olive Oil; Parkinson Disease, Secondary; Phenylethyl Alcohol; Substantia Nigra

2021